Form 8-K - Current report:
SEC Accession No. 0000078003-24-000185
Filing Date
2024-10-15
Accepted
2024-10-15 07:18:26
Documents
16
Period of Report
2024-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PFIZER 8-K OCTOBER 10 2024 pfe-20241010.htm   iXBRL 8-K 33509
2 EX-99.1 PRESS RELEASE ex99_pressreleasex1024v2.htm EX-99.1 11230
7 logo1a.jpg GRAPHIC 5525
  Complete submission text file 0000078003-24-000185.txt   219598

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20241010.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20241010_def.xml EX-101.DEF 15360
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20241010_lab.xml EX-101.LAB 27449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20241010_pre.xml EX-101.PRE 16027
18 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20241010_htm.xml XML 4273
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 241369249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)